GROVES REGINA E

SEC Form 4 insider trading activity

GROVES REGINA E has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including ATRC, FLGT, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.

On the most recent filing, GROVES REGINA E is listed as Director at AtriCure, Inc. Inside the rolling window, GROVES REGINA E reported no open-market purchases and 1 open-market sale totaling $288K in ATRC.

Companies traded

Other insiders at ATRC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$288K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
ATRC
GROVES REGINA E
Sale$288KSep 14SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has GROVES REGINA E made?

GROVES REGINA E has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including ATRC, FLGT since 2026.

Which companies does GROVES REGINA E trade?

GROVES REGINA E has filed SEC Form 4 disclosures for 2 companies, including ATRC, FLGT.

When was GROVES REGINA E's most recent SEC Form 4 filing?

GROVES REGINA E's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.

What is GROVES REGINA E's total buy and sell value in the current window?

Inside the rolling retention window, GROVES REGINA E bought $0 and sold $288K based on SEC Form 4 filings.

What was GROVES REGINA E's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,313 ATRC shares on 2026-09-11, worth $288K, per SEC Form 4 filings.